Dian Diagnostics' controlling shareholder pledges additional shares

Dian Diagnostics Group announced its controlling shareholder, Chen Haibin, has pledged 8,000,000 shares. This transaction represents 4.87% of Chen Haibin's total holdings and 1.28% of the company's total share capital. The pledge, effective October 31, 2025, with an expiration date of March 31, 2027, was executed with China Trust to repay other pledged borrowings.

Following this pledge, Chen Haibin's total pledged shares now amount to 84,460,000, which constitutes 51.36% of his personal holdings and 13.51% of the company's total share capital. The company clarified that Chen Haibin can repay the funds using salary, bonuses, stock dividends, and other income.

The company stated the share pledge will not materially affect its operations, corporate governance, or lead to a change in actual control. There are currently no risks of forced liquidation or transfer of the pledged shares.